In December 2023, cancer specialists from China and the US came together to attend the virtual 3rd China-US Anti-Cancer Summit, co-organised by the China Anti-Cancer Association (CACA) and the US-China Anti-Cancer Association (USCACA).

 

Anti-cancer leaders from China and the US took part in presentations and a panel discussion and exchanged ideas and perspectives on the following:

  • The development of holistic, integrative management of cancer in China
  • Cancer research progress in the US
  • Innovations in oncology: the role of ASCO in improving cancer care
  • Treatment of advanced lung cancer: current and future perspectives

 

The panel of experts also discussed how to collaborate internationally to ensure global relevance of locally generated trial data and to harmonise regulations for trial endpoints to strengthen the global fight against cancer.

 

Educational objectives

 

  • Share insights and perspectives on the management and treatment of cancer patients in the US and China
  • Inform oncologists about the current and future developments in lung cancer 
  • Generate awareness of the latest innovations and progress in cancer research in the US and China

Programme summary
  • clock Duration 150 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from BeiGene Europe, AmoyDx and Fosun Pharma.
Endorsement
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

video Video
Oncology 
Recent advances in precision oncology and future implications

Two emerging and two established targets

Experts
Prof. David Hong
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Survey on the evolving role of the oncology nurse in the USA

Announcing the publication of survey results 

Experts
Nina Grenon, Natasha Pinheiro, Karen Waldrop, Brittni Prosdocimo
  • download Downloadable
    Resources
  • clock 10 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Bayer.
video Video
Oncology 
Elacestrant in ER+/HER2- metastatic breast cancer

An expert overview of the EMERALD subgroup analysis

Experts
Dr Virginia Kaklamani
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
video Video
Oncology 
Systemic treatment options for patients with non-clear cell renal cell carcinoma (nccRCC)

Managing patients with nccRCC: guidelines, recommendations, and best practice

Experts
Prof. Laurence Albiges
Endorsed by
Urobel VZW | ASBL
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Eisai Europe Limited (“Eisai”). Eisai has had no input on the educational content of, or speakers involved in this programme. 
micro-learning Micro learning
Oncology 
Metastatic pancreatic ductal adenocarcinoma (PDAC): from diagnosis to treatment

Risk factors, diagnostic tools and treatment options for different patient groups

Experts
Prof. Efrat Dotan, Prof. Shubham Pant
Endorsed by
Digestive Cancers Europe
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Ipsen USA.
conference-update Conference update
Oncology 
Rezatapopt in TP53 Y220C mutated metastatic breast cancer: PYNNACLE phase 1/2 update

Exploring emerging treatment strategies presented at SABCS 2024

Experts
Prof. Frédérique Penault-Llorca, Dr Ecaterina E Dumbrava
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Dec 2024

This programme has been sponsored by PMV Pharma.